Table 2.
Patient outcomes
| Outcome | All patients (n = 1,935) |
|---|---|
| Major outcomes |
|
| ICU mortality |
242 (12.5) |
| Hospital mortality |
375 (19.4) |
| Re-admitted to ICU |
55 (2.8) |
| ICU length of stay (days) |
4 (2 to 7) |
| Hospital length of stay (days) |
12 (6 to 24) |
| Adjudicated outcomes |
|
| Leg thrombus |
42 (2.2) |
| Nonleg thrombusa |
52 (2.7) |
| Pulmonary embolism |
36 (1.9) |
| Any venous thromboembolism |
117 (6.0) |
| Heparin-induced thrombocytopenia |
3 (0.2) |
| Major bleeding |
187 (9.7) |
| Any bleeding | 457 (23.6) |
Data presented as number (percentage) or median (interquartile range). Venous thromboembolic outcomes, length of stay and mortality status of the 1,935 patients included in this audit, from 28 participating ICUs. Only the first ICU admissions during the audit month were considered. Outcomes are not mutually exclusive. aThromboses occurring in sites other than the lower extremities, including the head and neck, trunk, and upper extremities.